Dividend-adjusted total return · Aug 5, 2026 – Nov 3, 2026MHIP
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | +4.2% | +4.5% | — | — | — | — | +8.4% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $2M
- Expense ratio
- 0.55%
- Distribution yield
- 0.0%
- NAV
- $21.43
- Volume
- 7
- Avg. volume 30D
- 199
- High today
- $21.46
- Low today
- $21.41
- Previous close
- $21.46
- 52-week high
- $22.57
- 52-week low
- $19.45
- Our risk indicator
- 4/5
MHIP in One Breath
MHIP Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in MHIP
5Y$10,000 in MHIP became
$10,838
In the S&P 500 (VOO)
$10,774
Total return, dividends in · Apr 21, 2026 – Nov 3, 2026 · S&P 500 uses VOO
MHIP’s Top Holdings
TodayLLYEli Lilly &12.9%SPYM11.6%JNJ5.0%ABBV4.6%XFIV3.4%XHLF3.0%TMO2.9%GILD2.7%AMGN2.2%DHR1.9%ABT1.8%UNH1.5%ISRG1.5%PFE1.5%MDT1.3%SYK1.2%BMY1.2%CVS1.1%MCK1.0%HCA1.0%65 more
Drug Manufacturers - GeneralAsset Management - GlobalMedical - DiagnosticsMedical - DevicesAsset Management - BondsMedical - Healthcare PlansOther
Milliman MHIP · 87 holdings · tile size = share of the fund · as of Nov 3, 2026
What MHIP Holds
TodayDrug Manufacturers - General30.9%
LLY 12.9 · JNJ 5.0 · ABBV 4.6 · GILD 2.7 · AMGN 2.2 · PFE 1.5 · BMY 1.2
Asset Management - Global11.6%
SPYM 11.6
Medical - Diagnostics & Research9.5%
TMO 2.9 · DHR 1.9 · NTRA · WAT · IQV · A · DGX
Medical - Devices6.7%
ABT 1.8 · MDT 1.3 · SYK 1.2 · BSX · EW · DXCM · ZBH
Asset Management - Bonds6.4%
XFIV 3.4 · XHLF 3.0
Medical - Healthcare Plans5.3%
UNH 1.5 · CVS 1.1 · ELV · CI · CNC · HUM
Other holdings29.5%
ISRG 1.5 · MCK · HCA · VEEV · BDX · MDLN · RMD
Milliman MHIP · share of the fund by industry · as of Nov 3, 2026
Eli’s Share of MHIP
Today12.9%
$129 of every $1,000 in MHIP is Eli
Eli held by MHIP
$207K
Milliman MHIP · each square = $10 of $1,000 · as of Nov 3, 2026
MHIP’s Share of Health Care ETFs
Today0.0%
of the $109B in 39 Health care ETFs
$1.6M0.0%
$49.1B45.0%
$19.1B17.5%
$40.8B37.5%
Health care ETF AUM · Nov 4, 2026
MHIP Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside MHIP
87 holdings · as of Nov 3, 2026MHIP
Milliman Healthcare Inflation Plus ETF
TodayDrug Manufacturers - General30.9%LLYEli Lilly &12.9%JNJ5.0%ABBV4.6%GILD2.7%AMGN2.2%PFEBMYMRKAsset Management - Global11.6%SPYMState Street SPDR Portfolio S&P 500 ETF11.6%Medical - Diagnostics9.5%TMO2.9%DHRNTRAWATIQVADGXLHMedical - Devices6.7%ABT1.8%MDTSYKBSXEWDXCMAsset Management - Bonds6.4%XFIV3.4%XHLF3.0%Medical - Healthcare Plans5.3%UNHCVSELVCIOther29.5%ISRGMCKHCAVEEVBDX32 more holdings23.5% of the fund
Drug Manufacturers - General30.9%LLY12.9%JNJ5.0%ABBV4.6%GILDAMGNPFE3 moreAsset Management - Global11.6%SPYM11.6%Medical - Diagnostics9.5%TMODHRNTRAWAT8 moreMedical - Devices6.7%ABTMDTSYKEWDXCMAsset Management - Bonds6.4%XFIV3.4%XHLFMedical - Healthcare Plans5.3%UNHCVSELVCICNCHUMOther29.5%ISRGMCKHCA34 more holdings24.4% of the fund
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 12.90% |
| 2 | SPYM | State Street SPDR Portfolio S&P 500 ETF | 11.60% |
| 3 | JNJ | Johnson & Johnson | 5.00% |
| 4 | ABBV | AbbVie | 4.60% |
| 5 | XFIV | BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | 3.37% |
| 6 | XHLF | BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | 3.03% |
| 7 | TMO | Thermo Fisher Scientific | 2.93% |
| 8 | GILD | Gilead Sciences | 2.70% |
| 9 | AMGN | Amgen | 2.23% |
| 10 | DHR | Danaher | 1.91% |
Drug Manufacturers - GeneralAsset Management - GlobalMedical - DiagnosticsMedical - DevicesAsset Management - BondsMedical - Healthcare PlansOther
Milliman MHIP · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 63.3%
How It Compares
MHIP
Milliman Healthcare Inflation Plus ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put MHIP head to head with XLV →XLV vs MHIP
YTDYear to date
Level
Past year
Level
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV30545.5× more
2–0XLV wins
SPDR XLV and Milliman MHIP · year-to-date · as of Nov 4, 2026 · AUM not scored
MHIP vs Its Peer Average
YTDMHIPAvsBPeer average
1D0.0%+0.6%
1M+4.2%+4.0%
3M+4.5%+6.1%
YTD[…]+21.0%
1Y[…]+29.0%
3Y[…]+81.2%
5Y[…]+28.9%
1–2Peer average wins
38 Health care peers · each row scaled to its leader
The Details
MHIP
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y[…]
Deepest drop · 1Y[…]
Lowest point · 5Y−1.8%
52-week range
$21.46
$19.45−4.9% from the high$22.57
Milliman MHIP · past-year price moves · as of Nov 4, 2026
MHIP
Fund Facts
Today2026launched Apr 21
Tracks[…]
Exchange · CUSIPAMEX · 600825202
StructureETF
Leverage1x
Cost on $10,000$55 a year
Go deeper
Milliman MHIP · fund facts · as of Nov 4, 2026
MHIP
Payouts by Year
Today$0no payouts on record
MHIP does not pay a distribution.
Distribution yield0.0%
Paid[…]
Latest ex-date · paid[…]
12 payouts added up[…]
Milliman MHIP · distributions by ex-date
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$21.43
Premium / discount[…]
Median spread · 30D[…]
Volume today7
Average volume · 30D199
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.55%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$55.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
No payouts on record: […]
Issuer contentFrom MillimanHear the strategy from the people behind MHIP.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →